UniProt ID | WWTR1_HUMAN | |
---|---|---|
UniProt AC | Q9GZV5 | |
Protein Name | WW domain-containing transcription regulator protein 1 | |
Gene Name | WWTR1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 400 | |
Subcellular Localization | Nucleus. Cytoplasm. Concentrates along specific portions of the plasma membrane, and accumulates in punctate nuclear bodies. When phosphorylated, is retained in cytoplasm by YWHAZ. Can be retained in the nucleus by MED15. | |
Protein Description | Transcriptional coactivator which acts as a downstream regulatory target in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. WWTR1 enhances PAX8 and NKX2-1/TTF1-dependent gene activation. Regulates the nuclear accumulation of SMADS and has a key role in coupling them to the transcriptional machinery such as the mediator complex. Regulates embryonic stem-cell self-renewal, promotes cell proliferation and epithelial-mesenchymal transition.. | |
Protein Sequence | MNPASAPPPLPPPGQQVIHVTQDLDTDLEALFNSVMNPKPSSWRKKILPESFFKEPDSGSHSRQSSTDSSGGHPGPRLAGGAQHVRSHSSPASLQLGTGAGAAGSPAQQHAHLRQQSYDVTDELPLPPGWEMTFTATGQRYFLNHIEKITTWQDPRKAMNQPLNHMNLHPAVSSTPVPQRSMAVSQPNLVMNHQHQQQMAPSTLSQQNHPTQNPPAGLMSMPNALTTQQQQQQKLRLQRIQMERERIRMRQEELMRQEAALCRQLPMEAETLAPVQAAVNPPTMTPDMRSITNNSSDPFLNGGPYHSREQSTDSGLGLGCYSVPTTPEDFLSNVDEMDTGENAGQTPMNINPQQTRFPDFLDCLPGTNVDLGTLESEDLIPLFNDVESALNKSEPFLTWL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MNPASAPPPLPP ---CCCCCCCCCCCC | 42.43 | 22210691 | |
34 | Phosphorylation | DLEALFNSVMNPKPS CHHHHHHHHHCCCCH | 18.53 | 22210691 | |
41 | Phosphorylation | SVMNPKPSSWRKKIL HHHCCCCHHHHHCCC | 48.97 | 22210691 | |
46 | Ubiquitination | KPSSWRKKILPESFF CCHHHHHCCCCHHHC | 40.68 | 29967540 | |
51 | Phosphorylation | RKKILPESFFKEPDS HHCCCCHHHCCCCCC | 33.76 | 30177828 | |
58 | Phosphorylation | SFFKEPDSGSHSRQS HHCCCCCCCCCCCCC | 53.57 | 27273156 | |
60 | Phosphorylation | FKEPDSGSHSRQSST CCCCCCCCCCCCCCC | 23.42 | 23403867 | |
62 | Phosphorylation | EPDSGSHSRQSSTDS CCCCCCCCCCCCCCC | 33.44 | 22617229 | |
65 | Phosphorylation | SGSHSRQSSTDSSGG CCCCCCCCCCCCCCC | 33.81 | 29255136 | |
66 | Phosphorylation | GSHSRQSSTDSSGGH CCCCCCCCCCCCCCC | 28.09 | 27273156 | |
67 | Phosphorylation | SHSRQSSTDSSGGHP CCCCCCCCCCCCCCC | 45.18 | 29255136 | |
69 | Phosphorylation | SRQSSTDSSGGHPGP CCCCCCCCCCCCCCC | 30.85 | 30242111 | |
70 | Phosphorylation | RQSSTDSSGGHPGPR CCCCCCCCCCCCCCC | 52.16 | 27273156 | |
87 | Phosphorylation | GGAQHVRSHSSPASL CCCCCCCCCCCCCCE | 26.99 | 29255136 | |
89 | Phosphorylation | AQHVRSHSSPASLQL CCCCCCCCCCCCEEC | 38.98 | 29255136 | |
90 | Phosphorylation | QHVRSHSSPASLQLG CCCCCCCCCCCEECC | 21.04 | 29255136 | |
93 | Phosphorylation | RSHSSPASLQLGTGA CCCCCCCCEECCCCC | 21.74 | 30278072 | |
98 | Phosphorylation | PASLQLGTGAGAAGS CCCEECCCCCCCCCC | 32.24 | 29255136 | |
105 | Phosphorylation | TGAGAAGSPAQQHAH CCCCCCCCHHHHHHH | 16.61 | 29255136 | |
117 | Phosphorylation | HAHLRQQSYDVTDEL HHHHHHCCCCCCCCC | 18.24 | 22199227 | |
118 | Phosphorylation | AHLRQQSYDVTDELP HHHHHCCCCCCCCCC | 15.30 | 22199227 | |
121 | Phosphorylation | RQQSYDVTDELPLPP HHCCCCCCCCCCCCC | 22.36 | 22199227 | |
133 | Phosphorylation | LPPGWEMTFTATGQR CCCCCEEEEEECCCC | 13.30 | 20068231 | |
135 | Phosphorylation | PGWEMTFTATGQRYF CCCEEEEEECCCCHH | 17.72 | 20068231 | |
137 | Phosphorylation | WEMTFTATGQRYFLN CEEEEEECCCCHHHH | 30.69 | 20068231 | |
141 | Phosphorylation | FTATGQRYFLNHIEK EEECCCCHHHHHHHH | 12.44 | 27642862 | |
173 | Phosphorylation | MNLHPAVSSTPVPQR CCCCCCCCCCCCCCH | 30.51 | 29214152 | |
174 | Phosphorylation | NLHPAVSSTPVPQRS CCCCCCCCCCCCCHH | 30.08 | 25159151 | |
175 | Phosphorylation | LHPAVSSTPVPQRSM CCCCCCCCCCCCHHC | 22.31 | 25159151 | |
185 | Phosphorylation | PQRSMAVSQPNLVMN CCHHCCCCCCCCCCC | 30.31 | - | |
283 | Phosphorylation | QAAVNPPTMTPDMRS HHHCCCCCCCCCHHH | 34.63 | 27251275 | |
285 | Phosphorylation | AVNPPTMTPDMRSIT HCCCCCCCCCHHHHH | 20.72 | 27251275 | |
290 | Phosphorylation | TMTPDMRSITNNSSD CCCCCHHHHHCCCCC | 27.42 | 23403867 | |
292 | Phosphorylation | TPDMRSITNNSSDPF CCCHHHHHCCCCCCC | 29.60 | 23403867 | |
295 | Phosphorylation | MRSITNNSSDPFLNG HHHHHCCCCCCCCCC | 37.88 | 25159151 | |
296 | Phosphorylation | RSITNNSSDPFLNGG HHHHCCCCCCCCCCC | 51.96 | 23403867 | |
305 | Phosphorylation | PFLNGGPYHSREQST CCCCCCCCCCCCCCC | 18.72 | 23403867 | |
307 | Phosphorylation | LNGGPYHSREQSTDS CCCCCCCCCCCCCCC | 31.50 | 23403867 | |
311 | Phosphorylation | PYHSREQSTDSGLGL CCCCCCCCCCCCCCC | 29.45 | 18227151 | |
312 | Phosphorylation | YHSREQSTDSGLGLG CCCCCCCCCCCCCCC | 33.60 | 20736484 | |
314 | Phosphorylation | SREQSTDSGLGLGCY CCCCCCCCCCCCCCE | 35.69 | 20736484 | |
321 | Phosphorylation | SGLGLGCYSVPTTPE CCCCCCCEECCCCHH | 15.76 | - | |
322 | Phosphorylation | GLGLGCYSVPTTPED CCCCCCEECCCCHHH | 26.20 | 28348404 | |
325 | Phosphorylation | LGCYSVPTTPEDFLS CCCEECCCCHHHHHH | 53.48 | 28348404 | |
326 | Phosphorylation | GCYSVPTTPEDFLSN CCEECCCCHHHHHHC | 20.72 | 28348404 | |
332 | Phosphorylation | TTPEDFLSNVDEMDT CCHHHHHHCCCCCCC | 34.50 | 28348404 | |
339 | Phosphorylation | SNVDEMDTGENAGQT HCCCCCCCCCCCCCC | 45.12 | 28348404 | |
346 | Phosphorylation | TGENAGQTPMNINPQ CCCCCCCCCCCCCCC | 24.48 | - | |
392 | Sumoylation | DVESALNKSEPFLTW HHHHHHHCCCCCCCC | 57.98 | - | |
393 | Phosphorylation | VESALNKSEPFLTWL HHHHHHCCCCCCCCC | 49.80 | 20068231 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
89 | S | Phosphorylation | Kinase | LATS1 | O95835 | PSP |
89 | S | Phosphorylation | Kinase | LATS2 | Q9NRM7 | Uniprot |
90 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
105 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
285 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
311 | S | Phosphorylation | Kinase | LATS2 | Q9NRM7 | Uniprot |
321 | Y | Phosphorylation | Kinase | ARG | P42684 | PSP |
326 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
346 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | BTRC | Q9Y297 | PMID:20858893 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of WWTR1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of WWTR1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NHRF2_HUMAN | SLC9A3R2 | physical | 11118213 | |
KLF5_HUMAN | KLF5 | physical | 22045023 | |
PP1A_HUMAN | PPP1CA | physical | 21189257 | |
ASPP2_HUMAN | TP53BP2 | physical | 21189257 | |
FBW1A_HUMAN | BTRC | physical | 21189257 | |
1433E_HUMAN | YWHAE | physical | 21189257 | |
1433T_HUMAN | YWHAQ | physical | 21555462 | |
DVL2_HUMAN | DVL2 | physical | 20412773 | |
FBW1A_HUMAN | BTRC | physical | 20412773 | |
AMOL1_HUMAN | AMOTL1 | physical | 26186194 | |
AMOT_HUMAN | AMOT | physical | 26186194 | |
TEAD1_HUMAN | TEAD1 | physical | 26186194 | |
TEAD3_HUMAN | TEAD3 | physical | 26186194 | |
FBW1A_HUMAN | BTRC | physical | 26186194 | |
FBW1B_HUMAN | FBXW11 | physical | 26186194 | |
1433E_HUMAN | YWHAE | physical | 25961935 | |
TEAD4_HUMAN | TEAD4 | physical | 25670202 | |
FBW1A_HUMAN | BTRC | physical | 26116754 | |
TEAD4_HUMAN | TEAD4 | physical | 26116754 | |
FBW1A_HUMAN | BTRC | physical | 28018973 | |
TEAD1_HUMAN | TEAD1 | physical | 28514442 | |
TEAD3_HUMAN | TEAD3 | physical | 28514442 | |
FBW1A_HUMAN | BTRC | physical | 28514442 | |
TEAD1_HUMAN | TEAD1 | physical | 25796446 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-87 AND SER-105, AND MASSSPECTROMETRY. | |
"TAZ promotes cell proliferation and epithelial-mesenchymal transitionand is inhibited by the hippo pathway."; Lei Q.Y., Zhang H., Zhao B., Zha Z.Y., Bai F., Pei X.H., Zhao S.,Xiong Y., Guan K.L.; Mol. Cell. Biol. 28:2426-2436(2008). Cited for: FUNCTION, PHOSPHORYLATION AT SER-89 AND SER-311, AND MUTAGENESIS OFSER-89 AND SER-311. |